The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akash Sethi & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 0.2 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Akash Sethi, along with Persons Acting in Concert (Atul Kumar Sethi, Amita Sethi, Ashish Sethi), disclosed the acquisition of 75,150 equity shares (1.93% of diluted capital) and 2,25,450 warrants (5.78% of diluted capital) of Shree Pacetronix Ltd on 14 November 2025 through a preferential allotment worth approximately ₹2.43 crore. Post-acquisition, Akash Sethi's individual holding rose from 0.35% to 2.25% (equity) plus 5.78% via warrants, while the combined promoter group holding increased from 24.25% to 30.09% on a fully diluted basis, crossing the 25% open-offer threshold. The company's equity share capital expanded from ₹3.60 crore to ₹3.67 crore, with total diluted capital of ₹3.90 crore assuming full warrant conversion.
This is a promoter-group stake increase that signals continued insider confidence in the company. Existing minority shareholders may see equity dilution from the preferential issue and potential future dilution if the warrants are converted, though promoter commitment is generally viewed positively by the market.